(4) The SAP-dependent Mkl1 target genes are associated with a poor clinical outcome in breast cancer patients, not receiving adjuvant therapy or having a cancer classified as non-aggressive such as LN-negative, ER-positive, Grade 1 or 2 tumors. Here, ESR1 is linked to cancer.